Laird Norton Wetherby Wealth Management’s DexCom DXCM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $642K | Buy |
+7,355
| New | +$642K | 0.03% | 487 |
|
2024
Q4 | $580K | Buy |
7,456
+1,040
| +16% | +$80.9K | 0.03% | 482 |
|
2024
Q3 | $430K | Sell |
6,416
-3,184
| -33% | -$213K | 0.02% | 615 |
|
2024
Q2 | $1.09M | Sell |
9,600
-891
| -8% | -$101K | 0.05% | 329 |
|
2024
Q1 | $1.46M | Sell |
10,491
-62
| -0.6% | -$8.6K | 0.07% | 276 |
|
2023
Q4 | $1.31M | Buy |
10,553
+646
| +7% | +$80.2K | 0.07% | 287 |
|
2023
Q3 | $924K | Sell |
9,907
-530
| -5% | -$49.4K | 0.05% | 343 |
|
2023
Q2 | $1.34M | Sell |
10,437
-86
| -0.8% | -$11.1K | 0.07% | 278 |
|
2023
Q1 | $1.22M | Buy |
10,523
+56
| +0.5% | +$6.51K | 0.07% | 286 |
|
2022
Q4 | $1.19M | Buy |
10,467
+604
| +6% | +$68.4K | 0.08% | 289 |
|
2022
Q3 | $794K | Buy |
9,863
+1,621
| +20% | +$130K | 0.06% | 340 |
|
2022
Q2 | $614K | Sell |
8,242
-2,762
| -25% | -$206K | 0.04% | 429 |
|
2022
Q1 | $1.41M | Buy |
11,004
+292
| +3% | +$37.4K | 0.08% | 235 |
|
2021
Q4 | $1.44M | Buy |
10,712
+148
| +1% | +$19.9K | 0.08% | 228 |
|
2021
Q3 | $1.44M | Buy |
10,564
+332
| +3% | +$45.4K | 0.09% | 211 |
|
2021
Q2 | $1.09M | Buy |
10,232
+4,192
| +69% | +$447K | 0.07% | 271 |
|
2021
Q1 | $543K | Sell |
6,040
-4,564
| -43% | -$410K | 0.04% | 410 |
|
2020
Q4 | $980K | Buy |
10,604
+3,720
| +54% | +$344K | 0.07% | 275 |
|
2020
Q3 | $710K | Sell |
6,884
-36
| -0.5% | -$3.71K | 0.06% | 296 |
|
2020
Q2 | $701K | Buy |
6,920
+1,128
| +19% | +$114K | 0.07% | 286 |
|
2020
Q1 | $390K | Buy |
5,792
+1,548
| +36% | +$104K | 0.04% | 384 |
|
2019
Q4 | $232K | Buy |
+4,244
| New | +$232K | 0.02% | 617 |
|